Fierce Pharma

MAY 21, 2024

A decade ago, with AstraZeneca in decline and some investors urging the drugmaker to sell out to Pfizer, new CEO Pascal Soriot presented an audacious plan to hike revenue to $45 billion by 2023. | After AstraZeneca achieved Pascal Soriot's ambitious $45-billion-by-2023 revenue goal, the CEO is thinking big again. On Tuesday morning, AZ unveiled its new plan to swell its revenue to $80 billion by 2030.

294

294

Clarivate

MAY 21, 2024

We have released the first version of the Clarivate Academic AI Platform, serving our suite of AI-powered Research Assistants. Discover how it is going to help address the needs of students, researchers and librarians for trusted AI. At Clarivate TM , we understand the transformative power of artificial intelligence (AI) in the academic realm and the imperative to introduce AI thoughtfully and responsibly into research, teaching and learning environments.

Government 129

Government Ethics Management Specialization 129

Fierce Pharma

MAY 21, 2024

Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immuno | Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immunology approval.

238

238

MedCity News

MAY 21, 2024

Employers need healthcare data in order to make decisions, but the data isn’t always easy to get, experts said on a panel at MedCity INVEST. The post Why Healthcare Data Is Vital for Employers appeared first on MedCity News.

Healthcare 118

Healthcare Healthcare 118

Advertisement

Fierce Pharma

MAY 21, 2024

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its U.S. | Incyte revealed plans to purchase buildings at 1100 North King Street and 1100 North French street in downtown Wilmington, Delaware, where the company got its start back in 2002.

Medical 226

Medical 226

MedCity News

MAY 21, 2024

The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago. The post 5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow appeared first on MedCity News.

Biopharma 113

Biopharma 113

PM360

MAY 21, 2024

PM360’s Focus On section examines a specific area of the life sciences industry. In this issue, we take a closer look at the evolution of the Smart TV and the increase of streaming services and how they can benefit the pharma industry. From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say.

Media 105

Media Healthcare Healthcare Marketing 105

MedCity News

MAY 21, 2024

During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace. The post 4 Things Digital Health Investors Need To Get Off Their Chest appeared first on MedCity News.

Healthcare 103

Healthcare Healthcare 103

pharmaphorum

MAY 21, 2024

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

Competition 105

Competition FDA Patients 105

Scott Burrows

MAY 21, 2024

In the world of motivational speaking, stories of triumph over adversity are not uncommon. But for me, the narrative goes beyond inspiration—it’s about embodying the very principles of vision, mindset, and grit that have shaped my journey. At the age of 19, a car accident left me with a broken neck and a daunting diagnosis of quadriplegia. But from the confines of a wheelchair, I refused to let my circumstances define me.

Management 98

Management Marketing 98

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

MAY 21, 2024

AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.

107

107

MedCity News

MAY 21, 2024

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development. The post Importance of Patient Capital in Life Sciences appeared first on MedCity News.

Patients 89

Patients 89

pharmaphorum

MAY 21, 2024

Going against the advice of the CHMP, the EU has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy should stay on the market

Marketing 98

Marketing 98

PharmaVoice

MAY 21, 2024

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

116

116

Advertisement

Distribution

European Pharmaceutical Review

MAY 21, 2024

Initial data from a Phase III maintenance study of TREMFYA ® (guselkumab) has demonstrated promising remission rates obtained from a dual-acting monoclonal antibody given to ulcerative colitis (UC) patients. This data from Johnson & Johnson’s Phase III QUASAR study is being presented at Digestive Disease Week 2024 (Abstract #759). Achievement of clinical remission Fifty percent of patients with moderate to severe active ulcerative colitis given subcutaneous TREMFYA (guselkumab) 200mg every f

Patients 84

Patients Leads Pharmaceutical 84

Pharmaceutical Commerce

MAY 21, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.

Pharma 81

Pharma 81

Pharmaceutical Technology

MAY 21, 2024

Roche announced an FDA breakthrough therapy designation for its inavolisib/Ibrance combination therapy.

FDA 98

FDA 98

pharmaphorum

MAY 21, 2024

Digital investment in the pharma sector is continuing at a steady pace but could fall behind what is needed to deliver true transformation of their businesses.

Pharma 78

Pharma 78

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTimes

MAY 21, 2024

The network will support the development, evaluation and adoption of innovative health and care technology

Networking 90

Networking 90

Pharmaceutical Commerce

MAY 21, 2024

The latest news for pharma industry insiders.

Pharma 99

Pharma 99

PharmaTimes

MAY 21, 2024

The funding aims to reduce health inequalities in these groups and save more lives

89

89

PM360

MAY 21, 2024

EVERSANA and MyHealthTeam collaborate to help patients connect more quickly on social media regarding diagnosis and treatment. EVERSANA and MyHealthTeam Collaborate to Launch Direct-to-Patient Solution EVERSANA and MyHealthTeam announced that they have joined forces to help life sciences companies use the power of Artificial Intelligence (AI) and accelerate the time to diagnosis and treatment for millions of patients all over the world.

Media 52

Media Patients Medical Engineering 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmExec

MAY 21, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Tala Fakhouri, at Financial Times’ US Pharma and Biotech Summit, Tala Fakhouri, Associate Director for Policy Analysis, FDA, discusses whether the FDA plans on restricting the use of AI and what the future could look like when it comes to machine learning.

FDA 52

FDA Pharma 52

PM360

MAY 21, 2024

Gender imbalance was so ingrained in me as I grew up that, even as a woman, I have at times in my career been gender- blind. I was lucky enough to enter academia with a number of women colleagues. It was only later in my career that I started noticing the gender gap in the pharma industry. Minding the Gap In 2012, I was invited to a life science and pharma event in London as part of the Olympics.

Pharma 52

Pharma Pharmaceutical 52

Clarivate

MAY 21, 2024

With the goal of cancer treatment generally to extend a patient’s life for a meaningful length of time, overall survival (OS) is widely considered the ‘gold standard’ endpoint in oncology clinical trials [1] [2]. However, alternative oncology-relevant endpoints beyond OS offer great potential for supporting faster and more efficient access to therapies.

Food and Drug Administration 52

Food and Drug Administration Patients Consulting Marketing 52

PM360

MAY 21, 2024

From 19th century fiction like Pinocchio to modern science fiction like Star Trek, Artificial Intelligence (AI) has intrigued us with existential dilemmas and life-changing potential. It is unsurprising then that AI’s arrival has impacted Life Sciences so profoundly. AI has driven major advances across the Life Sciences value chain from molecule discovery to clinical trials to manufacturing.

Medical 52

Medical Patients Insurance Manufacturing 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Scott Burrows

MAY 21, 2024

In the world of keynote motivational speakers, there are those who inspire with words, and then there are those who inspire with their very existence. My journey, marked by triumph over adversity, serves as a testament to the power of the human spirit and the principles that guide us through life’s toughest challenges: vision, mindset, and grit.

Safety 52

Safety Specialization Healthcare Healthcare 52

PM360

MAY 21, 2024

In the ever-evolving landscape of pharmaceutical marketing, staying ahead necessitates innovation and adaptability. Traditional marketing approaches, while effective in the past, often struggle to engage modern audiences inundated with information from various channels. Enter modular content—a dynamic strategy that holds immense potential for pharmaceutical marketers seeking to connect meaningfully with their target audience.

Marketing 52

Marketing Pharmaceutical Distribution Healthcare 52

Scott Burrows

MAY 21, 2024

As an Inspirational Business and Sales Keynote speaker entrenched in the insurance and financial industry, I have a unique story to tell—one of resilience, determination, and ultimate triumph. My life-changing journey serves as the foundation for my presentations, where I strive to inspire audiences to believe that anything is possible, both personally and professionally.

Competition 52

Competition Insurance Marketing Sales 52

PM360

MAY 21, 2024

Navigating the complex healthcare system can be a stressful experience for patients, from obtaining a diagnosis to finding the right specialty care or treatment. To help alleviate some of the challenges patients face, it’s crucial to meet them with personalized resources that fit their needs at different stages throughout their journey. And thanks to recent innovations, that’s possible at the point of care and beyond.

Patients 52

Patients Prescription Side effects Doctors 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization